About
FDNA is a medical AI platform specializing in phenotypic image analysis and decision-support tools for diagnosing genetic and developmental conditions. Leveraging a proprietary multi-modal algorithm framework, FDNA combines facial image analysis, natural language processing, symptom assessments, video analysis, and voice analysis to identify health signals and match patients to potential syndromes. At the core of the platform is Deep Gestalt®, an algorithm that maps facial images to potential genetic syndromes, complemented by Gestalt Matcher™ for rare or newly discovered conditions. Additional tools include a Feature Extraction Algorithm that maps facial characteristics to HPO (Human Phenotype Ontology) terms, a Clinical Notes Analyzer for extracting biomarkers from health records, and Focus Assessment to reduce diagnostic ambiguity when multiple results are flagged. FDNA serves three key audiences: parents and patients who want to flag potential developmental issues at home, healthcare providers seeking decision-support and care management tools, and pharma companies and CROs that need streamlined patient data interoperability. With more than 100 peer-reviewed publications and deployment in over 10,000 hospitals and clinics worldwide, FDNA is a trusted partner in the rare disease diagnostics ecosystem. It is particularly well-suited for pediatric specialists, genetic counselors, and clinical researchers working with underdiagnosed or rare genetic conditions.
Key Features
- Deep Gestalt® Image Analysis: Maps facial images to potential genetic syndromes using a deep learning algorithm trained on a comprehensive phenotypic database.
- Multi-Modal Algorithm Framework: Integrates image analysis, symptom assessment, NLP, video, and voice analysis to cross-reference diagnostic signals across multiple input types.
- Gestalt Matcher™: Enables discovery of new or ultra-rare syndromes and supports patient-to-patient matching based on phenotypic similarity.
- Clinical Notes Analyzer: NLP-powered algorithm that extracts HPO terms, biomarkers, and symptoms from clinical notes and health records, supporting both text and voice input.
- Data Clearinghouse & Interoperability: Streamlines data exchange between patients, healthcare providers, pharmaceutical companies, and CROs to facilitate research and therapy pipelines.
Use Cases
- Pediatric clinicians using AI-powered facial image analysis to flag potential genetic syndromes during routine check-ups and refer patients to appropriate specialists faster.
- Parents concerned about their child's developmental milestones using FDNA's home screening tools to document symptoms and connect with genetic specialists.
- Genetic counselors leveraging Gestalt Matcher™ to identify rare or newly described syndromes in patients who have received no prior diagnosis.
- Pharmaceutical companies and CROs using FDNA's data clearinghouse to identify eligible patients for rare disease clinical trials and therapy pipelines.
- Hospital systems integrating FDNA's NLP Clinical Notes Analyzer to extract structured phenotypic data from unstructured health records for improved diagnostic accuracy.
Pros
- Globally Proven at Scale: Deployed in 10,000+ medical centers across 130+ countries with over 100 peer-reviewed publications validating its clinical utility.
- Comprehensive Multi-Modal Approach: Combines image, voice, video, symptom, and NLP analysis for a holistic and more accurate diagnostic decision-support system.
- Serves the Full Care Ecosystem: Supports parents, pediatric clinicians, genetic counselors, pharma companies, and CROs within a single connected platform.
Cons
- Enterprise-Focused Pricing: As a professional medical AI platform, pricing is geared toward healthcare institutions and pharma companies, making it less accessible for independent practitioners.
- Specialized Use Case: Narrowly focused on developmental and genetic disorder diagnostics, limiting applicability to other areas of healthcare or general-purpose AI use cases.
Frequently Asked Questions
Who is FDNA designed for?
FDNA is designed for three primary audiences: parents and patients who want to check for early developmental signs at home, healthcare providers (such as pediatricians and genetic counselors) who need decision-support tools, and pharmaceutical companies and CROs seeking patient data interoperability for research.
How does FDNA's image analysis work?
FDNA uses its proprietary Deep Gestalt® algorithm to analyze facial images and map phenotypic features to potential genetic syndromes. It cross-references these results using HPO terms, syndrome atrophy models, and a multi-modal framework that also incorporates symptom assessment and clinical notes.
What is Gestalt Matcher™?
Gestalt Matcher™ is FDNA's algorithm for identifying new or ultra-rare syndromes that may not yet be in existing databases. It also enables patient-to-patient phenotypic matching to support research on underdiagnosed conditions.
In how many countries is FDNA available?
FDNA's technology is used in over 130 countries and has been deployed across more than 10,000 medical centers, clinics, and hospitals worldwide.
Does FDNA support integration with health records?
Yes. FDNA's Clinical Notes Analyzer uses NLP to extract HPO terms, biomarkers, and symptoms directly from electronic health records and clinical notes. It supports both text and voice input, facilitating seamless integration into clinical workflows.
